XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Income Statement [Abstract]        
Net sales and revenue $ 174,877 $ 221,079 $ 484,263 $ 645,770
Cost of sales (includes $22,739 and $32,723 with related parties for the three months ended October 31, 2024 and 2023, respectively, and $81,726 and $92,610 with related parties for the nine months ended October 31, 2024 and 2023, respectively.) 135,196 181,789 410,358 577,962
Gross profit 39,681 39,290 73,905 67,808
Selling, general and administrative expenses (8,426) (7,609) (20,977) (21,996)
Equity in income of unconsolidated affiliates 3,621 4,738 7,086 9,275
Interest and other income, net 4,629 4,863 14,950 10,935
Income before income taxes 39,505 41,282 74,964 66,022
Provision for income taxes (9,402) (9,640) (17,581) (15,396)
Net income 30,103 31,642 57,383 50,626
Net income attributable to noncontrolling interests (5,603) (5,566) (10,314) (10,259)
Net income attributable to REX common shareholders $ 24,500 $ 26,076 $ 47,069 $ 40,367
Weighted average shares outstanding – basic (in Shares) 17,595 17,531 17,550 17,461
Basic net income per share attributable to REX common shareholders (in Dollars per share) $ 1.39 $ 1.49 $ 2.68 $ 2.31
Weighted average shares outstanding – diluted (in Shares) 17,723 17,531 17,673 17,461
Diluted net income per share attributable to REX common shareholders (in Dollars per share) $ 1.38 $ 1.49 $ 2.66 $ 2.31